Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Forward 50 2011

Nir Barzilai

The key to longevity may have less to do with lifestyle than with the predetermined makeup of your genes. That’s what Dr. Nir Barzilai, director of the Institute for Aging Research at the Albert Einstein College of Medicine of Yeshiva University, has found in his Longevity Genes Project by studying Ashkenazi Jews who have lived into their 90s and 100s.

This year, Barzilai and his colleagues reported that Jews who live past 95 have dietary habits, levels of alcohol consumption and physical activity similar to their shorter-lived counterparts — suggesting that genes for exceptional longevity could play a greater role than behavior in supporting long life. He had previously found that Jewish centenarians and their offspring are more protected from age-related diseases like cancer. In late October, the Israeli-born Barzilai was tapped to help lead a newly formed centenarian consortium for the Archon Genomics X Prize. The $10 million competition, which will start in 2013, challenges scientists to sequence the complete genomes of 100 healthy centenarians in 30 days. Barzilai will help identify and collect the 100 centenarian genomes to be sequenced, the Associated Press reported.

“By sequencing the genomes of these healthy centenarians — and making the results available to scientists — this contest will be a powerful tool in helping us decode the genetic underpinnings of healthy aging, and develop drugs that can mimic the protections these individuals have,” he said.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse..

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.